Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    23169517 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Study of Cabozantinib (XL184) in Adults With Advanced Malignancies
Conditions: Solid Tumors;   Cancer
Interventions: Drug: XL184;   Drug: Placebo

Indicates status has not been verified in more than two years